BriaCell Therapeutics Corp. Quarterly Earnings Per Share, Basic in USD/shares from Q3 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
BriaCell Therapeutics Corp. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2021 to Q2 2024.
  • BriaCell Therapeutics Corp. Earnings Per Share, Basic for the quarter ending July 31, 2024 was -0.07 USD/shares, a 50% increase year-over-year.
  • BriaCell Therapeutics Corp. Earnings Per Share, Basic for the twelve months ending July 31, 2024 was -0.29 USD/shares, a 77.7% increase year-over-year.
  • BriaCell Therapeutics Corp. annual Earnings Per Share, Basic for 2024 was -0.29 USD/shares, a 77.7% increase from 2023.
  • BriaCell Therapeutics Corp. annual Earnings Per Share, Basic for 2023 was -1.3 USD/shares, a 24.9% increase from 2022.
  • BriaCell Therapeutics Corp. annual Earnings Per Share, Basic for 2022 was -1.73 USD/shares, a 43.5% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0 $0 +$0.07 +50% May 1, 2024 Jul 31, 2024 10-K 2024-10-29
Q1 2024 $0 $0.11 +$0.43 Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 -$1 -$1 +$0.06 +7.79% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 -$1 $0.38 +$0.45 Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-14
Q2 2023 -$1 $0 May 1, 2023 Jul 31, 2023 10-K 2024-10-29
Q1 2023 $0 Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 -$1 -$1 -208% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 $0 +$1.74 +96.1% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-14
Q4 2021 $0.71 Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-16
Q3 2021 -$2 Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.